Literature DB >> 6609980

Induction of autoantibodies to thyroglobulin by anti-idiotypic antibodies.

M Zanetti, J Rogers, D H Katz.   

Abstract

We report on the induction of autoantibodies to thyroglobulin (Tg) and idiotype-positive molecules (Id') in naive BALB/c mice and Buffalo (BUF) rats after immunization with affinity-purified rabbit anti-Id antibodies directed against the Id of a mouse monoclonal antibody ( mAb62 ) specific for a hormone-containing epitope of Tg. Autoantibodies to Tg were produced in about one-half of anti-Id immunized mice, whereas Id' was detected in all but one mouse. Autoantibodies to Tg and Id' were not produced in control mice similarly immunized with non-anti-Id Ig. To clarify the relationship between molecules with Tg-binding activity and those referred to as Id', Tg-specific monoclonal antibodies were generated from an anti-Id-immunized mouse. By competitive inhibition experiments, we could determine that they were idiotypically very similar to the monoclonal antibody ( mAb62 ) at the origin of the immunologic cascade. Thus, autoantibodies induced by anti-idiotypic immunization alone are likely to be of the Ab1' type. Similarly, autoantibody to Tg and Id' molecules were induced in young normal rats of the autoimmune-prone BUF strain. Together, these results suggest that antibodies to Id directed against autoantigens are sufficient per se to activate self-reactivity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609980

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Molecular mimicry as a mechanism for virus-induced autoimmunity.

Authors:  R S Fujinami; M B Oldstone
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

Review 2.  Specificities of autoantibodies in autoimmune receptor diseases.

Authors:  M H De Baets
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

Review 3.  Premises for immune interventional therapy in rheumatoid arthritis.

Authors:  I R Mackay; M J Rowley
Journal:  Postgrad Med J       Date:  1988-07       Impact factor: 2.401

4.  Therapeutic treatment of New Zealand mouse disease by a limited number of anti-idiotypic antibodies conjugated with neocarzinostatin.

Authors:  N Harata; T Sasaki; H Osaki; T Saito; S Shibata; T Muryoi; O Takai; K Yoshinaga
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

5.  Familial systemic lupus erythematosus. Presence of a cross-reactive idiotype in healthy family members.

Authors:  R Halpern; A Davidson; A Lazo; G Solomon; R Lahita; B Diamond
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

6.  Selective elimination of anti-DNA antibody-producing cells by antiidiotypic antibody conjugated with neocarzinostatin.

Authors:  T Sasaki; T Muryoi; O Takai; E Tamate; Y Ono; Y Koide; N Ishida; K Yoshinaga
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

7.  Probing the human B-cell repertoire: isolation of Epstein-Barr virus (EBV)-transformed human B lymphocytes making antibodies with a common idiotope that have different antigen-binding specificities.

Authors:  Y Uchigata; B S Prabhakar; A L Notkins
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

8.  Multiple organ-reactive IgG antibody induced by an antiidiotypic antibody to a human monoclonal IgM autoantibody.

Authors:  K Essani; J Srinivasappa; P R McClintock; B S Prabhakar; A L Notkins
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.